Department of Defense PTSD Adaptive Platform Trial - Master Protocol

NCT05422612 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

800

Enrollment

OTHER

Sponsor class

Conditions

Post Traumatic Stress Disorder

Interventions

DRUG: Intervention A Fluoxetine Hydrochloride (HCl)
DRUG: Intervention A Placebo
DRUG: Intervention B Vilazodone Hydrochloride (HCl)
DRUG: Intervention B Placebo
DRUG: Intervention C Daridorexant
DRUG: Intervention C Placebo
DRUG: Intervention D SLS-002
DRUG: Intervention D Placebo

Sponsor

Global Coalition for Adaptive Research

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]